Clinical efficacy of cold snare endoscopic mucosal resection for＜20 mm colorectal laterally spreading tumor
10.3969/j.issn.1673-9701.2024.19.005
- VernacularTitle:冷内镜黏膜切除术对最大径＜20mm结直肠侧向发育型肿瘤的临床疗效
- Author:
Tongyun HE
1
;
Huifei LU
;
Piwei HU
;
Xinqiang WANG
;
Lei QIU
Author Information
1. 湖州市第一人民医院麻醉科,浙江湖州 313000
- Keywords:
Colorectal laterally spreading tumor;
Endoscopic mucosal resection;
Cold snare endoscopic mucosal resection;
Clinical effect
- From:
China Modern Doctor
2024;62(19):22-25,32
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy of cold snare endoscopic mucosal resection(CS-EMR)with conventional endoscopic mucosal resection(EMR)in the treatment of＜20 mm colorectal laterally spreading tumor(CLST).Methods A total of 248 CLST patients undergoing endoscopic resection treated in the First People's Hospital of Huzhou from January 2020 to June 2022 were selected and divided into EMR group and CS-EMR group according to random number table method,with 124 cases in each group.The general data,focal features,surgical indicators and complication rate of two groups were statistically compared.Results There were no significant differences in en bloc resection rate,complete resection rate and postoperative recurrence rate between two groups(P＞0.05).The operation time and hospital stay in CS-EMR group were significantly shorter than those in EMR group,the number of titanium clips and hospitalization costs were significantly lower than those in EMR group,and the incidence of intraoperative bleeding,delayed bleeding and delayed perforation were significantly lower than those in EMR group(P＜0.05).Conclusion In treatment of CLST with a maximum diameter of＜20mm,CS-EMR not only retains the advantages of fewer surgery-related complications,but also has similar therapeutic effect as EMR,and reduces the cost burden of patients,which is worthy of clinical reference and promotion.
